James H. MacCabe, FRCPsych, PhD

  • 5Articles
  • 26.5KReads1
  • 2002–2022Active
  • 33Collaborators
  • 138Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

James H. MacCabe, FRCPsych, PhD, is affiliated with King’s College London (Institute of Psychiatry, Psychology, and Neuroscience) and South London and Maudsley NHS Foundation Trust. His publications from 2002 to 2022 focus on schizophrenia, schizoaffective disorders, mood disorders, neurodevelopmental conditions, and obsessive-compulsive and related disorders. His research topics include the prevalence of obsessive-compulsive symptoms in psychotic and mood disorders, antipsychotic treatment outcomes in early-onset psychosis with comorbid autism spectrum disorders, and management strategies for clozapine rechallenge following adverse effects.

Publications

JCP
Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
Original Research

Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

September 28, 2022

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500 patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
, , , et al
JCP
Original Research

Autism and Antipsychotic Treatment

November 7, 2017

Read this article to see if the presence of ASD limited the effectiveness of antipsychotic treatment in youth with ASD and psychosis.
, , , et al
JCP
Original Research

Optimizing Outcomes in Clozapine Rechallenge Following Neutropenia: A Cohort Analysis

November 25, 2015

, , , et al
JCP
Letter to the Editor

Clozapine Rechallenge Following Clozapine-Induced Pericarditis

July 15, 2010

, ,
JCP
Letter to the Editor

Behavior Therapy Attenuates Clozapine-Induced Obsessions and Compulsions

December 1, 2002

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe